Aztreonam-avibactam (Emblaveo) photo source pfizer.nl KEY POINTS Aztreonam-avibactam (Emblaveo) is the combination of aztreonam (a monobactam) that interferes with bacterial cell wall synthesis and av...

This review covers important public health notices and clinical trials covering a broad range of infectious diseases topics from October 2023 to September

There is a growing body of evidence supporting early transition to oral antibiotic therapy to complete treatment courses for gram-negative bloodstream infections (GN-BSI) (1–3). Most available data fo...

In this article a selection of notable peer-reviewed publications from 2024 are provided. Article Selection by: Bassam Ghanem, Pharm.D., MS, BCPS Article Construction by: Timothy P. Gauthier, Pharm.D....

The degree of pyuria can help distinguish urinary tract infection (UTI) in older women from asymptomatic women with and without bacteriuria. We demonstrate

Penicillin allergy is a significant burden on patient, prescribing and hospital outcomes. There has been increasing interest in the incorporation of penicillin allergy testing (i.e. delabelling) into ...

MAD-ID offers an Annual Meeting where pharmacists, physicians, nurses and other healthcare providers will be given the opportunity to participate in this three-and-a-half-day educational program…

BlueSky combines customizable filters, an ad-free experience, and free API access for data analysis. Here's a simple guide to help you navigate the platform and connect with the #IDSky community.

Podcast Episode · Breakpoints · 10/29/2021 · 1 sec

As OPAT utilization increases, so does its associated research. Staying abreast of the emerging literature can be challenging. Herein a group of geographic

This consensus statement creates a clinical guideline for the diagnosis and management of urinary tract infections that addresses the gap between the evidence and recommendation strength.